Praram 9 Hospital Public Company Limited (PR9.BK)
- Previous Close
24.60 - Open
24.80 - Bid --
- Ask --
- Day's Range
24.40 - 25.75 - 52 Week Range
16.90 - 27.50 - Volume
4,936,487 - Avg. Volume
2,672,877 - Market Cap (intraday)
20.051B - Beta (5Y Monthly) 0.10
- PE Ratio (TTM)
28.02 - EPS (TTM)
0.91 - Earnings Date Aug 6, 2025 - Aug 11, 2025
- Forward Dividend & Yield 0.40 (1.63%)
- Ex-Dividend Date May 7, 2025
- 1y Target Est
29.63
Praram 9 Hospital Public Company Limited engages in hospital operations primarily in Thailand. The company operates medicine, surgery, diabetes and metabolic, spine, orthopedic, physical therapy and rehabilitation, chest and respiratory, neurology, thyroid and thyroid surgery, obstetrics gynecology, IVF, breast, oncocare, emergency, imaging, Lasik, skin and plastic surgery, mind, gastrointestinal and liver disease, dental, check-up, eye, pediatric, sleep, ear, nose, and throat centers, as well as vaccination and travel medicine, and traditional Chinese medicine clinics. It is also involved in the operation of kidney disease and transplantation, cardiovascular, and pain management and wellness institutes. Praram 9 Hospital Public Company Limited was founded in 1992 and is based in Bangkok, Thailand.
www.praram9.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: PR9.BK
View MorePerformance Overview: PR9.BK
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PR9.BK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PR9.BK
View MoreValuation Measures
Market Cap
19.34B
Enterprise Value
17.10B
Trailing P/E
27.03
Forward P/E
23.64
PEG Ratio (5yr expected)
1.37
Price/Sales (ttm)
4.17
Price/Book (mrq)
3.56
Enterprise Value/Revenue
3.69
Enterprise Value/EBITDA
14.63
Financial Highlights
Profitability and Income Statement
Profit Margin
15.19%
Return on Assets (ttm)
8.20%
Return on Equity (ttm)
13.55%
Revenue (ttm)
4.69B
Net Income Avi to Common (ttm)
712.68M
Diluted EPS (ttm)
0.91
Balance Sheet and Cash Flow
Total Cash (mrq)
2.24B
Total Debt/Equity (mrq)
0.09%
Levered Free Cash Flow (ttm)
624.71M